| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.63e-09 | 188 | 37 | 8 | GO:0005201 | |
| GeneOntologyMolecularFunction | integrin binding | 7.72e-07 | 175 | 37 | 6 | GO:0005178 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 9.06e-06 | 268 | 37 | 6 | GO:0005539 | |
| GeneOntologyMolecularFunction | structural constituent of synapse-associated extracellular matrix | 1.00e-05 | 3 | 37 | 2 | GO:0150043 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 9.93e-05 | 599 | 37 | 7 | GO:0050839 | |
| GeneOntologyMolecularFunction | structural molecule activity | 1.85e-04 | 891 | 37 | 8 | GO:0005198 | |
| GeneOntologyMolecularFunction | growth factor binding | 1.94e-04 | 156 | 37 | 4 | GO:0019838 | |
| GeneOntologyMolecularFunction | extracellular matrix constituent conferring elasticity | 2.18e-04 | 12 | 37 | 2 | GO:0030023 | |
| GeneOntologyMolecularFunction | glycosphingolipid binding | 2.57e-04 | 13 | 37 | 2 | GO:0043208 | |
| GeneOntologyMolecularFunction | structural molecule activity conferring elasticity | 3.00e-04 | 14 | 37 | 2 | GO:0097493 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 3.94e-04 | 16 | 37 | 2 | GO:0005041 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 6.86e-04 | 21 | 37 | 2 | GO:0030228 | |
| GeneOntologyMolecularFunction | transforming growth factor beta binding | 1.06e-03 | 26 | 37 | 2 | GO:0050431 | |
| GeneOntologyMolecularFunction | peptidase regulator activity | 1.27e-03 | 257 | 37 | 4 | GO:0061134 | |
| GeneOntologyMolecularFunction | sphingolipid binding | 1.81e-03 | 34 | 37 | 2 | GO:0046625 | |
| GeneOntologyMolecularFunction | RNA nuclease activity | 2.03e-03 | 136 | 37 | 3 | GO:0004540 | |
| GeneOntologyMolecularFunction | endonuclease activity | 2.03e-03 | 136 | 37 | 3 | GO:0004519 | |
| GeneOntologyMolecularFunction | calcium ion binding | 2.35e-03 | 749 | 37 | 6 | GO:0005509 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 2.91e-03 | 323 | 37 | 4 | GO:1901681 | |
| GeneOntologyMolecularFunction | glycolipid binding | 3.72e-03 | 49 | 37 | 2 | GO:0051861 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 4.02e-03 | 51 | 37 | 2 | GO:0043394 | |
| GeneOntologyMolecularFunction | peptidase inhibitor activity | 4.97e-03 | 187 | 37 | 3 | GO:0030414 | |
| GeneOntologyMolecularFunction | serine-type endopeptidase activity | 5.19e-03 | 190 | 37 | 3 | GO:0004252 | |
| GeneOntologyMolecularFunction | heparin binding | 5.35e-03 | 192 | 37 | 3 | GO:0008201 | |
| GeneOntologyMolecularFunction | serine-type peptidase activity | 6.58e-03 | 207 | 37 | 3 | GO:0008236 | |
| GeneOntologyMolecularFunction | serine hydrolase activity | 7.03e-03 | 212 | 37 | 3 | GO:0017171 | |
| GeneOntologyMolecularFunction | nuclease activity | 8.89e-03 | 231 | 37 | 3 | GO:0004518 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 9.41e-03 | 79 | 37 | 2 | GO:0004521 | |
| GeneOntologyMolecularFunction | collagen binding | 9.87e-03 | 81 | 37 | 2 | GO:0005518 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 1.08e-02 | 85 | 37 | 2 | GO:0038024 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 1.08e-02 | 85 | 37 | 2 | GO:0019199 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | 3.37e-08 | 410 | 37 | 9 | GO:0031589 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | 5.31e-07 | 748 | 37 | 10 | GO:0048667 | |
| GeneOntologyBiologicalProcess | axon guidance | 6.45e-07 | 285 | 37 | 7 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 6.60e-07 | 286 | 37 | 7 | GO:0097485 | |
| GeneOntologyBiologicalProcess | regulation of basement membrane organization | 8.68e-07 | 11 | 37 | 3 | GO:0110011 | |
| GeneOntologyBiologicalProcess | substrate adhesion-dependent cell spreading | 1.43e-06 | 109 | 37 | 5 | GO:0034446 | |
| GeneOntologyBiologicalProcess | positive regulation of integrin-mediated signaling pathway | 1.91e-06 | 14 | 37 | 3 | GO:2001046 | |
| GeneOntologyBiologicalProcess | integrin-mediated signaling pathway | 2.71e-06 | 124 | 37 | 5 | GO:0007229 | |
| GeneOntologyBiologicalProcess | neuron development | LAMB1 LAMB2 LAMC1 STRC FN1 AGRN PREX1 EPHA10 NTN3 NOTCH3 CRB2 STRCP1 | 5.42e-06 | 1463 | 37 | 12 | GO:0048666 |
| GeneOntologyBiologicalProcess | axonogenesis | 5.85e-06 | 566 | 37 | 8 | GO:0007409 | |
| GeneOntologyBiologicalProcess | regulation of integrin-mediated signaling pathway | 9.18e-06 | 23 | 37 | 3 | GO:2001044 | |
| GeneOntologyBiologicalProcess | neuron projection development | LAMB1 LAMB2 LAMC1 STRC FN1 AGRN PREX1 EPHA10 NTN3 NOTCH3 STRCP1 | 9.97e-06 | 1285 | 37 | 11 | GO:0031175 |
| GeneOntologyBiologicalProcess | axon development | 1.46e-05 | 642 | 37 | 8 | GO:0061564 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | 3.37e-05 | 1194 | 37 | 10 | GO:0000902 | |
| GeneOntologyBiologicalProcess | basement membrane organization | 6.24e-05 | 43 | 37 | 3 | GO:0071711 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | 7.15e-05 | 802 | 37 | 8 | GO:0048812 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | 8.28e-05 | 819 | 37 | 8 | GO:0120039 | |
| GeneOntologyBiologicalProcess | regulation of BMP signaling pathway | 8.72e-05 | 131 | 37 | 4 | GO:0030510 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | 8.78e-05 | 826 | 37 | 8 | GO:0048858 | |
| GeneOntologyBiologicalProcess | cell-matrix adhesion | 1.15e-04 | 270 | 37 | 5 | GO:0007160 | |
| GeneOntologyBiologicalProcess | extracellular matrix assembly | 1.61e-04 | 59 | 37 | 3 | GO:0085029 | |
| GeneOntologyBiologicalProcess | basement membrane assembly | 2.04e-04 | 12 | 37 | 2 | GO:0070831 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | 3.18e-04 | 1269 | 37 | 9 | GO:0009887 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 3.67e-04 | 347 | 37 | 5 | GO:0090092 | |
| GeneOntologyBiologicalProcess | hair cell differentiation | 3.68e-04 | 78 | 37 | 3 | GO:0035315 | |
| GeneOntologyBiologicalProcess | BMP signaling pathway | 4.17e-04 | 197 | 37 | 4 | GO:0030509 | |
| GeneOntologyBiologicalProcess | regulation of extracellular matrix organization | 4.58e-04 | 84 | 37 | 3 | GO:1903053 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 5.35e-04 | 377 | 37 | 5 | GO:0030198 | |
| GeneOntologyBiologicalProcess | extracellular structure organization | 5.42e-04 | 378 | 37 | 5 | GO:0043062 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 5.48e-04 | 379 | 37 | 5 | GO:0045229 | |
| GeneOntologyBiologicalProcess | response to BMP | 5.79e-04 | 215 | 37 | 4 | GO:0071772 | |
| GeneOntologyBiologicalProcess | cellular response to BMP stimulus | 5.79e-04 | 215 | 37 | 4 | GO:0071773 | |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus involved in sensory perception of sound | 7.74e-04 | 23 | 37 | 2 | GO:0050910 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | 7.99e-04 | 412 | 37 | 5 | GO:0090287 | |
| GeneOntologyBiologicalProcess | anterior/posterior axis specification, embryo | 8.43e-04 | 24 | 37 | 2 | GO:0008595 | |
| GeneOntologyBiologicalProcess | tripartite regional subdivision | 8.43e-04 | 24 | 37 | 2 | GO:0007351 | |
| GeneOntologyBiologicalProcess | positive regulation of muscle cell differentiation | 9.03e-04 | 106 | 37 | 3 | GO:0051149 | |
| GeneOntologyBiologicalProcess | auditory receptor cell stereocilium organization | 9.90e-04 | 26 | 37 | 2 | GO:0060088 | |
| GeneOntologyBiologicalProcess | inner ear development | 1.06e-03 | 253 | 37 | 4 | GO:0048839 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 1.13e-03 | 445 | 37 | 5 | GO:0141091 | |
| GeneOntologyBiologicalProcess | positive regulation of epithelial cell proliferation | 1.35e-03 | 270 | 37 | 4 | GO:0050679 | |
| GeneOntologyBiologicalProcess | segmentation | 1.39e-03 | 123 | 37 | 3 | GO:0035282 | |
| GeneOntologyBiologicalProcess | auditory receptor cell morphogenesis | 1.41e-03 | 31 | 37 | 2 | GO:0002093 | |
| GeneOntologyBiologicalProcess | inner ear morphogenesis | 1.59e-03 | 129 | 37 | 3 | GO:0042472 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | 1.61e-03 | 482 | 37 | 5 | GO:0007178 | |
| GeneOntologyBiologicalProcess | ear development | 1.65e-03 | 285 | 37 | 4 | GO:0043583 | |
| GeneOntologyBiologicalProcess | sensory organ development | 1.75e-03 | 730 | 37 | 6 | GO:0007423 | |
| GeneOntologyBiologicalProcess | blastoderm segmentation | 1.79e-03 | 35 | 37 | 2 | GO:0007350 | |
| GeneOntologyBiologicalProcess | auditory receptor cell development | 2.34e-03 | 40 | 37 | 2 | GO:0060117 | |
| GeneOntologyBiologicalProcess | ear morphogenesis | 2.63e-03 | 154 | 37 | 3 | GO:0042471 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | LAMB1 LAMB2 LAMC1 HTRA1 FBN1 FN1 SSPOP LTBP4 AGRN NTN3 PCSK6 | 8.50e-10 | 530 | 36 | 11 | GO:0062023 |
| GeneOntologyCellularComponent | basement membrane | 1.41e-09 | 122 | 36 | 7 | GO:0005604 | |
| GeneOntologyCellularComponent | extracellular matrix | LAMB1 LAMB2 LAMC1 HTRA1 FBN1 FN1 SSPOP LTBP4 AGRN NTN3 PCSK6 | 7.86e-09 | 656 | 36 | 11 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | LAMB1 LAMB2 LAMC1 HTRA1 FBN1 FN1 SSPOP LTBP4 AGRN NTN3 PCSK6 | 8.12e-09 | 658 | 36 | 11 | GO:0030312 |
| GeneOntologyCellularComponent | laminin complex | 5.58e-07 | 10 | 36 | 3 | GO:0043256 | |
| GeneOntologyCellularComponent | protein complex involved in cell-matrix adhesion | 3.14e-06 | 17 | 36 | 3 | GO:0098637 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 3.15e-06 | 59 | 36 | 4 | GO:0098636 | |
| GeneOntologyCellularComponent | laminin-10 complex | 8.64e-06 | 3 | 36 | 2 | GO:0043259 | |
| GeneOntologyCellularComponent | laminin-11 complex | 8.64e-06 | 3 | 36 | 2 | GO:0043260 | |
| GeneOntologyCellularComponent | laminin-1 complex | 8.64e-06 | 3 | 36 | 2 | GO:0005606 | |
| GeneOntologyCellularComponent | synaptic cleft | 2.47e-05 | 33 | 36 | 3 | GO:0043083 | |
| GeneOntologyCellularComponent | microfibril | 2.22e-04 | 13 | 36 | 2 | GO:0001527 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 2.47e-04 | 332 | 36 | 5 | GO:0005788 | |
| GeneOntologyCellularComponent | kinocilium | 2.59e-04 | 14 | 36 | 2 | GO:0060091 | |
| GeneOntologyCellularComponent | 9+2 non-motile cilium | 2.59e-04 | 14 | 36 | 2 | GO:0097732 | |
| GeneOntologyCellularComponent | cell surface | 4.95e-04 | 1111 | 36 | 8 | GO:0009986 | |
| GeneOntologyCellularComponent | stereocilium tip | 6.52e-04 | 22 | 36 | 2 | GO:0032426 | |
| GeneOntologyCellularComponent | stereocilium | 6.29e-03 | 69 | 36 | 2 | GO:0032420 | |
| GeneOntologyCellularComponent | stereocilium bundle | 8.17e-03 | 79 | 36 | 2 | GO:0032421 | |
| HumanPheno | Recurrent subcortical infarcts | 4.20e-05 | 4 | 14 | 2 | HP:0007236 | |
| HumanPheno | Lacunar stroke | 1.05e-04 | 6 | 14 | 2 | HP:0032325 | |
| HumanPheno | Ischemic stroke | 1.32e-04 | 38 | 14 | 3 | HP:0002140 | |
| HumanPheno | Cerebral infarct | 1.43e-04 | 39 | 14 | 3 | HP:0025722 | |
| HumanPheno | Vascular granular osmiophilic material deposition | 1.46e-04 | 7 | 14 | 2 | HP:0003657 | |
| Domain | EGF_1 | LAMB1 LAMB2 LAMC1 ITGBL1 FBN1 STAB2 FN1 NAGPA SSPOP LTBP4 AGRN NTN3 NOTCH3 CRB2 | 1.59e-17 | 255 | 36 | 14 | PS00022 |
| Domain | EGF_2 | LAMB1 LAMB2 LAMC1 ITGBL1 FBN1 STAB2 NAGPA SSPOP LTBP4 AGRN EPHA10 NTN3 NOTCH3 CRB2 | 2.73e-17 | 265 | 36 | 14 | PS01186 |
| Domain | EGF-like_CS | LAMB1 LAMB2 LAMC1 FBN1 STAB2 FN1 NAGPA LTBP4 AGRN EPHA10 NTN3 NOTCH3 CRB2 | 9.98e-16 | 261 | 36 | 13 | IPR013032 |
| Domain | EGF | LAMB1 LAMB2 LAMC1 ITGBL1 FBN1 STAB2 NAGPA LTBP4 AGRN PCSK6 NOTCH3 CRB2 | 1.14e-14 | 235 | 36 | 12 | SM00181 |
| Domain | EGF-like_dom | LAMB1 LAMB2 LAMC1 ITGBL1 FBN1 STAB2 NAGPA LTBP4 AGRN PCSK6 NOTCH3 CRB2 | 2.28e-14 | 249 | 36 | 12 | IPR000742 |
| Domain | Growth_fac_rcpt_ | 2.61e-13 | 156 | 36 | 10 | IPR009030 | |
| Domain | EGF_LAM_2 | 1.90e-11 | 30 | 36 | 6 | PS50027 | |
| Domain | EGF_LAM_1 | 1.90e-11 | 30 | 36 | 6 | PS01248 | |
| Domain | EGF_Lam | 5.16e-11 | 35 | 36 | 6 | SM00180 | |
| Domain | Laminin_EGF | 8.73e-11 | 38 | 36 | 6 | IPR002049 | |
| Domain | Galactose-bd-like | 4.83e-10 | 94 | 36 | 7 | IPR008979 | |
| Domain | Laminin_EGF | 6.20e-09 | 35 | 36 | 5 | PF00053 | |
| Domain | EGF_3 | 1.25e-08 | 235 | 36 | 8 | PS50026 | |
| Domain | LAMININ_NTER | 2.08e-08 | 16 | 36 | 4 | PS51117 | |
| Domain | Laminin_N | 2.08e-08 | 16 | 36 | 4 | PF00055 | |
| Domain | Laminin_N | 2.08e-08 | 16 | 36 | 4 | IPR008211 | |
| Domain | LamNT | 2.08e-08 | 16 | 36 | 4 | SM00136 | |
| Domain | EGF_CA | 1.14e-07 | 122 | 36 | 6 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.25e-07 | 124 | 36 | 6 | IPR001881 | |
| Domain | EGF | 4.11e-06 | 126 | 36 | 5 | PF00008 | |
| Domain | EGF_extracell | 5.25e-06 | 60 | 36 | 4 | IPR013111 | |
| Domain | EGF_2 | 5.25e-06 | 60 | 36 | 4 | PF07974 | |
| Domain | LAMININ_IVB | 1.08e-05 | 3 | 36 | 2 | PS51116 | |
| Domain | Laminin_IV_B | 1.08e-05 | 3 | 36 | 2 | IPR013015 | |
| Domain | - | 1.15e-05 | 73 | 36 | 4 | 2.60.120.260 | |
| Domain | EGF_Ca-bd_CS | 3.54e-05 | 97 | 36 | 4 | IPR018097 | |
| Domain | EGF_CA | 3.84e-05 | 99 | 36 | 4 | PS01187 | |
| Domain | ASX_HYDROXYL | 4.00e-05 | 100 | 36 | 4 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 5.02e-05 | 106 | 36 | 4 | IPR000152 | |
| Domain | TB | 7.54e-05 | 7 | 36 | 2 | PF00683 | |
| Domain | - | 1.00e-04 | 8 | 36 | 2 | 3.90.290.10 | |
| Domain | TB | 1.29e-04 | 9 | 36 | 2 | PS51364 | |
| Domain | TB_dom | 1.29e-04 | 9 | 36 | 2 | IPR017878 | |
| Domain | EGF_CA | 6.03e-04 | 86 | 36 | 3 | PF07645 | |
| Domain | TIMP-like_OB-fold | 1.14e-03 | 26 | 36 | 2 | IPR008993 | |
| Domain | hEGF | 1.32e-03 | 28 | 36 | 2 | PF12661 | |
| Domain | Kringle-like | 1.73e-03 | 32 | 36 | 2 | IPR013806 | |
| Domain | Kazal_2 | 2.18e-03 | 36 | 36 | 2 | PF07648 | |
| Domain | LAM_G_DOMAIN | 2.43e-03 | 38 | 36 | 2 | PS50025 | |
| Domain | LDLR_class-A_CS | 2.69e-03 | 40 | 36 | 2 | IPR023415 | |
| Domain | LamG | 3.25e-03 | 44 | 36 | 2 | SM00282 | |
| Domain | Ldl_recept_a | 3.39e-03 | 45 | 36 | 2 | PF00057 | |
| Domain | KAZAL | 3.54e-03 | 46 | 36 | 2 | SM00280 | |
| Domain | - | 3.54e-03 | 46 | 36 | 2 | 4.10.400.10 | |
| Domain | LDLRA_1 | 3.85e-03 | 48 | 36 | 2 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 4.01e-03 | 49 | 36 | 2 | IPR002172 | |
| Domain | LDLa | 4.01e-03 | 49 | 36 | 2 | SM00192 | |
| Domain | LDLRA_2 | 4.01e-03 | 49 | 36 | 2 | PS50068 | |
| Domain | KAZAL_2 | 4.18e-03 | 50 | 36 | 2 | PS51465 | |
| Domain | Kazal_dom | 4.34e-03 | 51 | 36 | 2 | IPR002350 | |
| Domain | Laminin_G | 5.58e-03 | 58 | 36 | 2 | IPR001791 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 1.98e-08 | 84 | 30 | 6 | M7098 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 1.42e-07 | 59 | 30 | 5 | M27218 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.49e-07 | 300 | 30 | 8 | M610 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 2.51e-07 | 66 | 30 | 5 | M18 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 4.39e-07 | 30 | 30 | 4 | M27772 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 4.39e-07 | 30 | 30 | 4 | M39641 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 4.39e-07 | 30 | 30 | 4 | MM15812 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 5.11e-07 | 76 | 30 | 5 | M27219 | |
| Pathway | PID_INTEGRIN4_PATHWAY | 1.42e-06 | 11 | 30 | 3 | M158 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 1.60e-06 | 41 | 30 | 4 | M27778 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 1.94e-06 | 43 | 30 | 4 | M53 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | 5.80e-06 | 124 | 30 | 5 | M27285 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.05e-05 | 140 | 30 | 5 | M587 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 2.24e-05 | 79 | 30 | 4 | M27643 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 2.86e-05 | 84 | 30 | 4 | M3228 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 3.40e-05 | 30 | 30 | 3 | M27216 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 4.14e-05 | 32 | 30 | 3 | MM14854 | |
| Pathway | WP_ALPHA_6_BETA_4_SIGNALING | 4.55e-05 | 33 | 30 | 3 | M39503 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 4.83e-05 | 96 | 30 | 4 | M39834 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 6.44e-05 | 37 | 30 | 3 | M27134 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 7.55e-05 | 39 | 30 | 3 | MM14601 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 1.01e-04 | 43 | 30 | 3 | M39565 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 1.09e-04 | 44 | 30 | 3 | M26969 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PLASMIN_MEDIATED_ACTIVATION_OF_LATENT_TGF_BETA | 1.22e-04 | 8 | 30 | 2 | M47850 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 1.24e-04 | 46 | 30 | 3 | M239 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.94e-04 | 258 | 30 | 5 | MM14572 | |
| Pathway | BIOCARTA_PRION_PATHWAY | 2.85e-04 | 12 | 30 | 2 | M22020 | |
| Pathway | WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY | 3.64e-04 | 66 | 30 | 3 | MM15925 | |
| Pathway | PID_INTEGRIN5_PATHWAY | 5.84e-04 | 17 | 30 | 2 | M212 | |
| Pathway | WP_FOCAL_ADHESION | 6.27e-04 | 187 | 30 | 4 | MM15913 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 7.64e-04 | 85 | 30 | 3 | M16441 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 7.69e-04 | 532 | 30 | 6 | M27870 | |
| Pathway | WP_FOCAL_ADHESION | 7.92e-04 | 199 | 30 | 4 | M39402 | |
| Pathway | KEGG_FOCAL_ADHESION | 7.92e-04 | 199 | 30 | 4 | M7253 | |
| Pathway | REACTOME_EGR2_AND_SOX10_MEDIATED_INITIATION_OF_SCHWANN_CELL_MYELINATION | 1.72e-03 | 29 | 30 | 2 | M29808 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.78e-03 | 114 | 30 | 3 | MM14571 | |
| Pathway | REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION | 2.93e-03 | 38 | 30 | 2 | MM15456 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 2.93e-03 | 38 | 30 | 2 | MM14874 | |
| Pathway | REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION | 3.09e-03 | 39 | 30 | 2 | M10735 | |
| Pathway | REACTOME_SYNTHESIS_OF_PA | 3.09e-03 | 39 | 30 | 2 | M653 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 3.40e-03 | 143 | 30 | 3 | M27275 | |
| Pathway | REACTOME_SYNTHESIS_OF_PA | 3.41e-03 | 41 | 30 | 2 | MM14583 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 3.65e-03 | 302 | 30 | 4 | M39719 | |
| Pathway | WP_CANCER_PATHWAYS | 3.99e-03 | 507 | 30 | 5 | M48302 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 4.09e-03 | 45 | 30 | 2 | MM15344 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 4.46e-03 | 47 | 30 | 2 | MM14925 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 4.46e-03 | 47 | 30 | 2 | M646 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 4.65e-03 | 48 | 30 | 2 | M27642 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 4.73e-03 | 325 | 30 | 4 | M12868 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 4.79e-03 | 326 | 30 | 4 | MM15917 | |
| Pathway | WP_PI3KAKT_SIGNALING | 5.49e-03 | 339 | 30 | 4 | M39736 | |
| Pubmed | 2.77e-12 | 146 | 37 | 8 | 27068509 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 4.31e-12 | 248 | 37 | 9 | 24006456 | |
| Pubmed | 8.18e-12 | 167 | 37 | 8 | 22159717 | ||
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 1.01e-11 | 97 | 37 | 7 | 27559042 | |
| Pubmed | 1.19e-11 | 175 | 37 | 8 | 28071719 | ||
| Pubmed | Proteomics characterization of extracellular space components in the human aorta. | 1.35e-11 | 101 | 37 | 7 | 20551380 | |
| Pubmed | Laminin-10 and Lutheran blood group glycoproteins in adhesion of human endothelial cells. | 1.62e-11 | 6 | 37 | 4 | 16236823 | |
| Pubmed | 3.78e-11 | 7 | 37 | 4 | 11891225 | ||
| Pubmed | 4.09e-11 | 118 | 37 | 7 | 21078624 | ||
| Pubmed | Adamts18 modulates the development of the aortic arch and common carotid artery. | 6.66e-11 | 26 | 37 | 5 | 34189436 | |
| Pubmed | 6.79e-11 | 64 | 37 | 6 | 22261194 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 1.06e-10 | 135 | 37 | 7 | 28675934 | |
| Pubmed | 1.20e-10 | 29 | 37 | 5 | 22613833 | ||
| Pubmed | Functional analysis of secreted and transmembrane proteins critical to mouse development. | 1.71e-10 | 31 | 37 | 5 | 11431694 | |
| Pubmed | 7.69e-10 | 13 | 37 | 4 | 12682087 | ||
| Pubmed | Sequencing of laminin B chain cDNAs reveals C-terminal regions of coiled-coil alpha-helix. | 1.11e-09 | 3 | 37 | 3 | 6209134 | |
| Pubmed | 2.10e-09 | 50 | 37 | 5 | 23658023 | ||
| Pubmed | TGF-beta-1 up-regulates extra-cellular matrix production in mouse hepatoblasts. | 3.28e-09 | 18 | 37 | 4 | 23041440 | |
| Pubmed | 3.28e-09 | 18 | 37 | 4 | 11311202 | ||
| Pubmed | ADAMTS18-fibronectin interaction regulates the morphology of liver sinusoidal endothelial cells. | 3.28e-09 | 18 | 37 | 4 | 39040056 | |
| Pubmed | 4.43e-09 | 4 | 37 | 3 | 24951930 | ||
| Pubmed | Regulation and Function of Laminin A5 during Mouse and Human Decidualization. | 4.43e-09 | 4 | 37 | 3 | 35008625 | |
| Pubmed | Changes in laminin isoforms associated with brain tumor invasion and angiogenesis. | 4.43e-09 | 4 | 37 | 3 | 16146715 | |
| Pubmed | 4.43e-09 | 4 | 37 | 3 | 8034675 | ||
| Pubmed | 1.11e-08 | 5 | 37 | 3 | 7670489 | ||
| Pubmed | 1.11e-08 | 5 | 37 | 3 | 10964500 | ||
| Pubmed | 1.11e-08 | 5 | 37 | 3 | 12743034 | ||
| Pubmed | 1.36e-08 | 153 | 37 | 6 | 25037231 | ||
| Pubmed | 2.21e-08 | 6 | 37 | 3 | 1678389 | ||
| Pubmed | Structural elucidation of full-length nidogen and the laminin-nidogen complex in solution. | 2.21e-08 | 6 | 37 | 3 | 23948589 | |
| Pubmed | 2.21e-08 | 6 | 37 | 3 | 2119632 | ||
| Pubmed | 2.21e-08 | 6 | 37 | 3 | 26555376 | ||
| Pubmed | Effect of basement membrane entactin on epidermal cell attachment and growth. | 2.21e-08 | 6 | 37 | 3 | 3794389 | |
| Pubmed | 2.21e-08 | 6 | 37 | 3 | 20874775 | ||
| Pubmed | Laminin-nidogen complex. Extraction with chelating agents and structural characterization. | 2.21e-08 | 6 | 37 | 3 | 3109910 | |
| Pubmed | 2.21e-08 | 6 | 37 | 3 | 10671376 | ||
| Pubmed | 3.87e-08 | 7 | 37 | 3 | 7921537 | ||
| Pubmed | 3.87e-08 | 7 | 37 | 3 | 14557481 | ||
| Pubmed | Extracellular-matrix gene expression during mouse submandibular gland development. | 6.18e-08 | 8 | 37 | 3 | 9382709 | |
| Pubmed | Linkage of genes for laminin B1 and B2 subunits on chromosome 1 in mouse. | 6.18e-08 | 8 | 37 | 3 | 2993224 | |
| Pubmed | Adamts18 Deficiency Causes Spontaneous SMG Fibrogenesis in Adult Mice. | 6.98e-08 | 37 | 37 | 4 | 34323105 | |
| Pubmed | 9.27e-08 | 9 | 37 | 3 | 22688677 | ||
| Pubmed | 9.27e-08 | 9 | 37 | 3 | 9827803 | ||
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | 1.10e-07 | 560 | 37 | 8 | 21653829 | |
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | 1.15e-07 | 219 | 37 | 6 | 31353912 | |
| Pubmed | 1.32e-07 | 10 | 37 | 3 | 9034910 | ||
| Pubmed | Regional differences in the expression of laminin isoforms during mouse neural tube development. | 1.82e-07 | 11 | 37 | 3 | 21524702 | |
| Pubmed | Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities. | 1.82e-07 | 11 | 37 | 3 | 23472759 | |
| Pubmed | 2.42e-07 | 12 | 37 | 3 | 9396756 | ||
| Pubmed | Basal lamina molecules are concentrated in myogenic regions of the mouse limb bud. | 3.15e-07 | 13 | 37 | 3 | 9833687 | |
| Pubmed | 3.15e-07 | 13 | 37 | 3 | 36350252 | ||
| Pubmed | Laminin alpha5 chain is required for intestinal smooth muscle development. | 5.00e-07 | 15 | 37 | 3 | 12921739 | |
| Pubmed | Basement membrane composition in the early mouse embryo day 7. | 5.00e-07 | 15 | 37 | 3 | 15895400 | |
| Pubmed | Patterns of laminins and integrins in the embryonic ventricular zone of the CNS. | 6.15e-07 | 16 | 37 | 3 | 17948866 | |
| Pubmed | 6.15e-07 | 16 | 37 | 3 | 17601529 | ||
| Pubmed | 7.46e-07 | 17 | 37 | 3 | 18082680 | ||
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 19037100 | ||
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 30859180 | ||
| Pubmed | Fibrillin-1 microfibril deposition is dependent on fibronectin assembly. | 1.10e-06 | 2 | 37 | 2 | 18653538 | |
| Pubmed | cDNA cloning, expression and mapping of human laminin B2 gene to chromosome 1q31. | 1.10e-06 | 2 | 37 | 2 | 3402995 | |
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 20939100 | ||
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 34910522 | ||
| Pubmed | A laminin-like adhesive protein concentrated in the synaptic cleft of the neuromuscular junction. | 1.10e-06 | 2 | 37 | 2 | 2922051 | |
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 9151673 | ||
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 29599141 | ||
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 11687802 | ||
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 20731416 | ||
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 28076935 | ||
| Pubmed | Enhanced Notch3 signaling contributes to pulmonary emphysema in a Murine Model of Marfan syndrome. | 1.10e-06 | 2 | 37 | 2 | 32616814 | |
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 21876163 | ||
| Pubmed | Complex contributions of fibronectin to initiation and maturation of microfibrils. | 1.10e-06 | 2 | 37 | 2 | 24070235 | |
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 23056244 | ||
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 22782528 | ||
| Pubmed | The C-terminal region of laminin beta chains modulates the integrin binding affinities of laminins. | 1.10e-06 | 2 | 37 | 2 | 19147489 | |
| Pubmed | 1.25e-06 | 20 | 37 | 3 | 22911573 | ||
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 1.54e-06 | 79 | 37 | 4 | 18757743 | |
| Pubmed | Renal collecting system growth and function depend upon embryonic γ1 laminin expression. | 1.93e-06 | 23 | 37 | 3 | 21903675 | |
| Pubmed | Neural crest cell-autonomous roles of fibronectin in cardiovascular development. | 2.21e-06 | 24 | 37 | 3 | 26552887 | |
| Pubmed | ERp57 is essential for efficient folding of glycoproteins sharing common structural domains. | 2.51e-06 | 25 | 37 | 3 | 17170699 | |
| Pubmed | 2.83e-06 | 26 | 37 | 3 | 24742657 | ||
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 2100263 | ||
| Pubmed | Immunohistochemical localization of extracellular matrix proteins in developing lung tissues. | 3.30e-06 | 3 | 37 | 2 | 17334455 | |
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 1907584 | ||
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 7698745 | ||
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 26057585 | ||
| Pubmed | Cochlear outer hair cell horizontal top connectors mediate mature stereocilia bundle mechanics. | 3.30e-06 | 3 | 37 | 2 | 30801007 | |
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 1292752 | ||
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 10481268 | ||
| Pubmed | Monocytic cells synthesize, adhere to, and migrate on laminin-8 (alpha 4 beta 1 gamma 1). | 3.30e-06 | 3 | 37 | 2 | 11067943 | |
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 7669546 | ||
| Pubmed | Three-dimensional analysis of the developing pituitary gland in the mouse. | 3.30e-06 | 3 | 37 | 2 | 9603432 | |
| Pubmed | Evaluation of JUN, FN1 and LAMB1 polymorphisms in pterygium in a Chinese Han population. | 3.30e-06 | 3 | 37 | 2 | 35445627 | |
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 10814726 | ||
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 30578652 | ||
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 9043083 | ||
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 21276136 | ||
| Pubmed | An association of IgG anti-laminin-1 autoantibodies with endometriosis in infertile patients. | 3.30e-06 | 3 | 37 | 2 | 12615822 | |
| Pubmed | Molecular structure and interaction of recombinant human type XVI collagen. | 3.30e-06 | 3 | 37 | 2 | 15165854 | |
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 18474427 | ||
| Pubmed | Differential expression of laminin A and B chains during development of embryonic mouse organs. | 3.30e-06 | 3 | 37 | 2 | 2088723 | |
| Interaction | FBXO2 interactions | 3.23e-08 | 411 | 36 | 9 | int:FBXO2 | |
| Interaction | ATXN7 interactions | 3.72e-08 | 109 | 36 | 6 | int:ATXN7 | |
| Interaction | CFC1 interactions | 8.85e-08 | 126 | 36 | 6 | int:CFC1 | |
| Interaction | CRP interactions | 2.45e-07 | 77 | 36 | 5 | int:CRP | |
| Interaction | TSHR interactions | 7.40e-07 | 96 | 36 | 5 | int:TSHR | |
| Interaction | ZFP41 interactions | 3.17e-06 | 57 | 36 | 4 | int:ZFP41 | |
| Interaction | MANEA interactions | 3.89e-06 | 60 | 36 | 4 | int:MANEA | |
| Interaction | DNAJC10 interactions | 6.13e-06 | 260 | 36 | 6 | int:DNAJC10 | |
| Interaction | IGFL3 interactions | 9.52e-06 | 75 | 36 | 4 | int:IGFL3 | |
| Interaction | NTN5 interactions | 1.03e-05 | 24 | 36 | 3 | int:NTN5 | |
| Interaction | NID2 interactions | 1.64e-05 | 86 | 36 | 4 | int:NID2 | |
| Interaction | SDF2L1 interactions | 2.06e-05 | 322 | 36 | 6 | int:SDF2L1 | |
| Interaction | LTBP1 interactions | 2.14e-05 | 92 | 36 | 4 | int:LTBP1 | |
| Interaction | HOXA1 interactions | 3.63e-05 | 356 | 36 | 6 | int:HOXA1 | |
| Interaction | CD48 interactions | 4.58e-05 | 39 | 36 | 3 | int:CD48 | |
| Interaction | WDR76 interactions | 5.45e-05 | 383 | 36 | 6 | int:WDR76 | |
| Interaction | LAMA5 interactions | 5.51e-05 | 117 | 36 | 4 | int:LAMA5 | |
| Interaction | NELL1 interactions | 5.73e-05 | 42 | 36 | 3 | int:NELL1 | |
| Interaction | CACNA1A interactions | 6.69e-05 | 123 | 36 | 4 | int:CACNA1A | |
| Interaction | GGH interactions | 6.80e-05 | 243 | 36 | 5 | int:GGH | |
| Interaction | FBLN1 interactions | 8.05e-05 | 129 | 36 | 4 | int:FBLN1 | |
| Interaction | TMEM25 interactions | 9.33e-05 | 134 | 36 | 4 | int:TMEM25 | |
| Interaction | MFAP5 interactions | 1.09e-04 | 52 | 36 | 3 | int:MFAP5 | |
| Interaction | PRG2 interactions | 1.44e-04 | 285 | 36 | 5 | int:PRG2 | |
| Interaction | WDR25 interactions | 1.51e-04 | 58 | 36 | 3 | int:WDR25 | |
| Interaction | HRG interactions | 1.93e-04 | 63 | 36 | 3 | int:HRG | |
| Interaction | SCGB1A1 interactions | 2.02e-04 | 12 | 36 | 2 | int:SCGB1A1 | |
| Interaction | FBLN2 interactions | 2.22e-04 | 66 | 36 | 3 | int:FBLN2 | |
| Interaction | FIBIN interactions | 2.75e-04 | 71 | 36 | 3 | int:FIBIN | |
| Interaction | CCL3 interactions | 2.78e-04 | 178 | 36 | 4 | int:CCL3 | |
| Interaction | PI15 interactions | 4.36e-04 | 83 | 36 | 3 | int:PI15 | |
| Interaction | LY86 interactions | 5.88e-04 | 217 | 36 | 4 | int:LY86 | |
| Interaction | ELSPBP1 interactions | 5.89e-04 | 92 | 36 | 3 | int:ELSPBP1 | |
| Interaction | OS9 interactions | 6.08e-04 | 219 | 36 | 4 | int:OS9 | |
| Interaction | CLEC11A interactions | 6.67e-04 | 96 | 36 | 3 | int:CLEC11A | |
| Cytoband | 15q15.3 | 1.87e-04 | 25 | 37 | 2 | 15q15.3 | |
| GeneFamily | Laminin subunits | 6.48e-07 | 12 | 27 | 3 | 626 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 5.00e-12 | 191 | 37 | 9 | MM17059 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 6.31e-12 | 196 | 37 | 9 | M3008 | |
| Coexpression | NABA_CORE_MATRISOME | 1.11e-10 | 270 | 37 | 9 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 1.30e-10 | 275 | 37 | 9 | M5884 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 2.69e-09 | 40 | 37 | 5 | M5887 | |
| Coexpression | NABA_MATRISOME | LAMB1 LAMB2 LAMC1 HTRA1 MST1L FBN1 FN1 SSPOP LTBP4 AGRN NTN3 PCSK6 | 7.47e-09 | 1008 | 37 | 12 | MM17056 |
| Coexpression | NABA_MATRISOME | LAMB1 LAMB2 LAMC1 HTRA1 MST1L FBN1 FN1 SSPOP LTBP4 AGRN NTN3 PCSK6 | 9.09e-09 | 1026 | 37 | 12 | M5889 |
| Coexpression | SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP | 5.40e-07 | 352 | 37 | 7 | M17471 | |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | 9.84e-07 | 385 | 37 | 7 | M39264 | |
| Coexpression | NABA_MATRISOME_BLEO_FIBROTIC_LUNG | 2.90e-06 | 20 | 37 | 3 | MM17053 | |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_2 | 3.91e-06 | 303 | 37 | 6 | M39040 | |
| Coexpression | DESCARTES_FETAL_EYE_STROMAL_CELLS | 8.22e-06 | 91 | 37 | 4 | M40180 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | 9.43e-06 | 767 | 37 | 8 | M39209 | |
| Coexpression | FAN_EMBRYONIC_CTX_BIG_GROUPS_BRAIN_ENDOTHELIAL | 1.13e-05 | 365 | 37 | 6 | M39018 | |
| Coexpression | CUI_DEVELOPING_HEART_C3_FIBROBLAST_LIKE_CELL | 2.22e-05 | 117 | 37 | 4 | M39300 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS_TUMOR_CELL_DERIVED | 2.90e-05 | 6 | 37 | 2 | M48000 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_MID_SCHWANN_CELL | 3.59e-05 | 268 | 37 | 5 | M45796 | |
| Coexpression | RUBENSTEIN_SKELETAL_MUSCLE_FBN1_FAP_CELLS | 5.14e-05 | 289 | 37 | 5 | M41750 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | 6.95e-05 | 505 | 37 | 6 | M39167 | |
| Coexpression | DASU_IL6_SIGNALING_UP | 8.81e-05 | 61 | 37 | 3 | M14344 | |
| Coexpression | ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE | 1.02e-04 | 64 | 37 | 3 | M2572 | |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN | 1.06e-04 | 337 | 37 | 5 | M13206 | |
| Coexpression | ZHANG_UTERUS_C0_SECRETORY_STROMAL3_NPPC_HIGH_CELL | 1.06e-04 | 337 | 37 | 5 | MM16606 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPERIC | 1.07e-04 | 795 | 37 | 7 | M39050 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP | 1.27e-04 | 69 | 37 | 3 | M10165 | |
| Coexpression | DESCARTES_FETAL_PLACENTA_EXTRAVILLOUS_TROPHOBLASTS | 1.33e-04 | 70 | 37 | 3 | M40277 | |
| Coexpression | GU_PDEF_TARGETS_UP | 1.39e-04 | 71 | 37 | 3 | M3955 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN | 1.57e-04 | 74 | 37 | 3 | M13547 | |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 1.59e-04 | 194 | 37 | 4 | M39122 | |
| Coexpression | GSE10239_MEMORY_VS_KLRG1HIGH_EFF_CD8_TCELL_UP | 1.75e-04 | 199 | 37 | 4 | M3060 | |
| Coexpression | GSE17721_CTRL_VS_CPG_8H_BMDC_DN | 1.78e-04 | 200 | 37 | 4 | M3768 | |
| Coexpression | GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_60H_DN | 1.78e-04 | 200 | 37 | 4 | M9657 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 1.78e-04 | 200 | 37 | 4 | M5930 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_LYMPHATIC_ENDOTHELIAL_CELL | 1.90e-04 | 382 | 37 | 5 | M45756 | |
| Coexpression | TRAVAGLINI_LUNG_LYMPHATIC_CELL | 2.11e-04 | 209 | 37 | 4 | M41670 | |
| Coexpression | PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP | 2.19e-04 | 211 | 37 | 4 | M12225 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN | 2.38e-04 | 905 | 37 | 7 | M40865 | |
| Coexpression | REN_ALVEOLAR_RHABDOMYOSARCOMA_DN | 2.55e-04 | 407 | 37 | 5 | M19541 | |
| Coexpression | JI_CARCINOGENESIS_BY_KRAS_AND_STK11_DN | 2.60e-04 | 17 | 37 | 2 | M1767 | |
| Coexpression | JI_CARCINOGENESIS_BY_KRAS_AND_STK11_DN | 2.60e-04 | 17 | 37 | 2 | MM1225 | |
| Coexpression | ZHANG_UTERUS_C2_SECRETORY_STROMAL3_RAMP3_HIGH_CELL | 2.99e-04 | 229 | 37 | 4 | MM16607 | |
| Coexpression | FARMER_BREAST_CANCER_CLUSTER_4 | 3.27e-04 | 19 | 37 | 2 | M15125 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_LATE_SCHWANN_CELL | 3.48e-04 | 97 | 37 | 3 | M45794 | |
| Coexpression | CAIRO_LIVER_DEVELOPMENT_DN | 3.51e-04 | 239 | 37 | 4 | MM1274 | |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | 3.52e-04 | 681 | 37 | 6 | M39175 | |
| Coexpression | IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN | 4.65e-04 | 107 | 37 | 3 | M4913 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 4.81e-04 | 23 | 37 | 2 | M48001 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | 4.93e-04 | 470 | 37 | 5 | MM1053 | |
| Coexpression | MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_INDEPENDENT | 5.25e-04 | 24 | 37 | 2 | M38986 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 5.37e-04 | 479 | 37 | 5 | M2573 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 5.58e-04 | 483 | 37 | 5 | MM1082 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_PROLIFERATING_SCHWANN_CELL | 5.96e-04 | 1054 | 37 | 7 | M45798 | |
| Coexpression | FOROUTAN_INTEGRATED_TGFB_EMT_UP | 6.49e-04 | 120 | 37 | 3 | M42505 | |
| Coexpression | AIZARANI_LIVER_C33_STELLATE_CELLS_2 | 7.48e-04 | 126 | 37 | 3 | M39132 | |
| Coexpression | NABA_MATRISOME_HIGHLY_METASTATIC_BREAST_CANCER_TUMOR_CELL_DERIVED | 7.69e-04 | 29 | 37 | 2 | M47987 | |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 7.69e-04 | 29 | 37 | 2 | MM17055 | |
| Coexpression | NABA_MATRISOME_METASTATIC_COLORECTAL_LIVER_METASTASIS | 8.23e-04 | 30 | 37 | 2 | M47990 | |
| Coexpression | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP | 8.77e-04 | 305 | 37 | 4 | M19875 | |
| Coexpression | ZHANG_UTERUS_C1_PROLIFERATIVE_STROMAL1_MGP_HIGH_CELL | 9.32e-04 | 310 | 37 | 4 | MM16608 | |
| Coexpression | HALLMARK_COAGULATION | 9.73e-04 | 138 | 37 | 3 | M5946 | |
| Coexpression | ROZANOV_MMP14_TARGETS_SUBSET | 9.96e-04 | 33 | 37 | 2 | M9167 | |
| Coexpression | PETRETTO_CARDIAC_HYPERTROPHY | 1.06e-03 | 34 | 37 | 2 | M14043 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR | 1.12e-03 | 35 | 37 | 2 | MM17054 | |
| Coexpression | ZHONG_PFC_MAJOR_TYPES_ASTROCYTES | 1.12e-03 | 326 | 37 | 4 | M39074 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 3.51e-08 | 437 | 36 | 9 | GSM777046_500 | |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | 3.12e-07 | 85 | 36 | 5 | GSM777067_100 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 6.04e-07 | 97 | 36 | 5 | GSM777043_100 | |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | 7.23e-07 | 453 | 36 | 8 | GSM777067_500 | |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | 7.47e-07 | 455 | 36 | 8 | GSM777055_500 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 8.94e-07 | 466 | 36 | 8 | GSM777050_500 | |
| CoexpressionAtlas | Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4 | 7.65e-06 | 439 | 36 | 7 | GSM777059_500 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 8.36e-06 | 445 | 36 | 7 | GSM777043_500 | |
| CoexpressionAtlas | Stromal Cells, LEC.SLN, gp38+ CD31+, Lymph Node, avg-4 | 8.99e-06 | 450 | 36 | 7 | GSM777063_500 | |
| CoexpressionAtlas | Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4 | 1.67e-05 | 91 | 36 | 4 | GSM777059_100 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.83e-04 | 168 | 36 | 4 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k4_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000 | 2.74e-04 | 773 | 36 | 7 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | 2.82e-04 | 777 | 36 | 7 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 | |
| CoexpressionAtlas | Mesoderm Day 15_vs_Mesoderm Day 5-Confounder_removed-fold2.0_adjp0.05 | 3.03e-04 | 1049 | 36 | 8 | PCBC_ratio_MESO-15_vs_MESO-5_cfr-2X-p05 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000 | 3.29e-04 | 797 | 36 | 7 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 4.30e-04 | 87 | 36 | 3 | GSM777050_100 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.91e-04 | 91 | 36 | 3 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k3_1000 | |
| CoexpressionAtlas | Stromal Cells, LEC.SLN, gp38+ CD31+, Lymph Node, avg-4 | 5.74e-04 | 96 | 36 | 3 | GSM777063_100 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 5.91e-04 | 97 | 36 | 3 | GSM777046_100 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_1000 | 7.05e-04 | 905 | 36 | 7 | gudmap_kidney_P0_JuxtaGlom_Ren1_1000 | |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_1000_k-means-cluster#1 | 7.87e-04 | 107 | 36 | 3 | JC_hmvEC_1000_K1 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#1_top-relative-expression-ranked_1000 | 8.98e-04 | 112 | 36 | 3 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k1_1000 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.30e-12 | 192 | 37 | 8 | beac6b3c191b11add8e39e8d04562b478ea8929e | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.44e-12 | 193 | 37 | 8 | 428b1a3ad87dff7f65de5161d40f102572a9341b | |
| ToppCell | facs-Lung-nan|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.89e-12 | 196 | 37 | 8 | b05f77f3990b662682ffeaf0e4c2fb190e0a6e65 | |
| ToppCell | facs-Lung-nan-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.89e-12 | 196 | 37 | 8 | 787c6cd92035e0b1108c2c086c42a229016e476b | |
| ToppCell | facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-10 | 186 | 37 | 7 | a7ab70b049742dfe7ee30557031bfac6412edf52 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.06e-10 | 191 | 37 | 7 | 1b26056df078674f37a6c06f6256b30cfcec21a7 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.38e-10 | 195 | 37 | 7 | 1236dc60288c7dd91868e86e9174a2dacd3b11b3 | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 2.38e-10 | 195 | 37 | 7 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 2.38e-10 | 195 | 37 | 7 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.74e-10 | 199 | 37 | 7 | 40de6d4a31cf22efa2864f79e4ec8e2b7bfc9d4a | |
| ToppCell | LA-01._Fibroblast_I|LA / Chamber and Cluster_Paper | 7.65e-09 | 179 | 37 | 6 | dcb6ec9ae72b13fe388b72dace2815293fafe8ee | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.45e-09 | 182 | 37 | 6 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.32e-09 | 185 | 37 | 6 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | facs-Trachea-nan-24m-Mesenchymal|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.93e-09 | 187 | 37 | 6 | 71385068e3fd0bfa7822ae176113a49460c8636b | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 9.93e-09 | 187 | 37 | 6 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | facs-Trachea-nan-24m-Mesenchymal-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.93e-09 | 187 | 37 | 6 | e891e571f6bb9433a0046215de6cabd89ed1effc | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-08 | 188 | 37 | 6 | 7191087d8754f5e8700e3d744cd920ee26db1e57 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.03e-08 | 188 | 37 | 6 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-08 | 189 | 37 | 6 | 378f26f751ab4b470948c35dd8347de72dd12ff7 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-08 | 189 | 37 | 6 | f0a2d4ef9896d764971ebbc6952510c128bb76e8 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.13e-08 | 191 | 37 | 6 | 0fae1c2ef9f83ac7721d0a9d69455bf97eed9257 | |
| ToppCell | LV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.13e-08 | 191 | 37 | 6 | d36565257ccba8c1bbed2c1c01be66a9cbb5f834 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.13e-08 | 191 | 37 | 6 | 094c9d3270fc1e487ccf10fb4936af5f081f6009 | |
| ToppCell | facs-Lung-24m-Mesenchymal|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.13e-08 | 191 | 37 | 6 | ba02cbdfda6a94374a6472eb88499059979af472 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-08 | 192 | 37 | 6 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.16e-08 | 192 | 37 | 6 | 32acd89617934016cd135d2cc797e8e79ae1b37f | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.16e-08 | 192 | 37 | 6 | 321850b0f881420c2d57d3e825e365c82fa511ab | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-08 | 192 | 37 | 6 | a2c31390da4962bda9a936470b0b68fa1f5d47d1 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.16e-08 | 192 | 37 | 6 | cdc652dbfabe41b324fd85c1ed933d29fb73a49f | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-08 | 192 | 37 | 6 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.16e-08 | 192 | 37 | 6 | 29bee88b45e23f16543ffc7cc361bc5da5d16a2b | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.16e-08 | 192 | 37 | 6 | cf2765d8bc074f7f9ee864eae632a3b705175842 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.16e-08 | 192 | 37 | 6 | 7b48df661f61ce494bf6f0b9a74b0422e29c24bf | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-08 | 192 | 37 | 6 | eeab1cef7c36ae824381952c5b2c982368c379fd | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.20e-08 | 193 | 37 | 6 | b05361ffe111a38cfa26eb86e4ae62c15ac99b7b | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-08 | 193 | 37 | 6 | eff718664fe0aaf89050efd9cc7b6dfb1df46666 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-08 | 193 | 37 | 6 | 858a186804b36d45957238d3d3eed2768b961641 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-08 | 193 | 37 | 6 | d9c20a092b507c43fcf7ccb04073fecd27d1749c | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Mesenchymal-mesenchymal_stem_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-08 | 193 | 37 | 6 | 160691b671710be10220803d788c2c961c236af1 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-08 | 193 | 37 | 6 | 7865e7ec0a288249540d4cba94ae01c93e1b617c | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-08 | 193 | 37 | 6 | 45b5cab4dfeb0ed3b13631db5963740a792b810f | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.24e-08 | 194 | 37 | 6 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 1.24e-08 | 194 | 37 | 6 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-08 | 195 | 37 | 6 | 69a29d03e664b72f32d41876510c62345c3aed31 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.28e-08 | 195 | 37 | 6 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | ASK428-Mesenchymal|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.28e-08 | 195 | 37 | 6 | 2b156163975d9a3d3fda1402acd9831d0fdc9e25 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-08 | 195 | 37 | 6 | 1cffae2b08dbfa1c633ce24023e89b66d28b5431 | |
| ToppCell | ASK428-Mesenchymal-Fibroblast|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.28e-08 | 195 | 37 | 6 | c269c0d894a0f55da6495b59d4b9abb9f68df684 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-08 | 195 | 37 | 6 | 9cef6f18664518060af7c192310dddce6d70345a | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.28e-08 | 195 | 37 | 6 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.32e-08 | 196 | 37 | 6 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | facs-Heart-LA-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-08 | 197 | 37 | 6 | 2a91738cb6d7588869dd00deeea0cbbc2d6aa34d | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.36e-08 | 197 | 37 | 6 | c165c6fd12dc649b39e920d8528e2eb65c61956b | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.36e-08 | 197 | 37 | 6 | 2872a78b1be61aa1d50bc9a49294a21e922dc033 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.40e-08 | 198 | 37 | 6 | eb78b2ae6a787dbc75947e8dd5a03693285bc8be | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.40e-08 | 198 | 37 | 6 | 8b9e8eaeffda40912a0163fdf39b93bc5e64751c | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.40e-08 | 198 | 37 | 6 | f1374f7a50244d59c766ac41f44c08c9117407d2 | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-08 | 198 | 37 | 6 | 0dc7d59a07428a7b7e8bdc81f0e2417dd4ce3cf2 | |
| ToppCell | Fibroblasts-CD34+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.44e-08 | 199 | 37 | 6 | 13ff7409e200a0b46cdb7924d15ef33639693622 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.44e-08 | 199 | 37 | 6 | 0019cfaa586a450c2e4952d1184a540561c8d0ba | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.44e-08 | 199 | 37 | 6 | 84545ced0c792bc77980a50d65e484eab648d47e | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.44e-08 | 199 | 37 | 6 | 66a79732caf2f04c09b4d9832377aa01ca477677 | |
| ToppCell | ASK452-Mesenchymal-Fibroblast|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.44e-08 | 199 | 37 | 6 | 4d0bf2a4bd97e5a3bfe4570a201cc21bb9c4c1f6 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.44e-08 | 199 | 37 | 6 | e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b | |
| ToppCell | ASK452-Mesenchymal|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.44e-08 | 199 | 37 | 6 | 93e85e3731a9ece9aee3eb82c5dfdad331ee62d6 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.48e-08 | 200 | 37 | 6 | f6be0f24e607abb9007823a54fb0b24d04990a89 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.48e-08 | 200 | 37 | 6 | 933b5b400e48a511ba0a056be1d33d3610b5f10d | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.48e-08 | 200 | 37 | 6 | 8978867bf69c830b1e48cac2ad6b512dbe60f149 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.48e-08 | 200 | 37 | 6 | 3a164e3971bcd62b148b813171c103adb81f972e | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.48e-08 | 200 | 37 | 6 | cbf6a6c3db88bac37bd084a3a914b12b3af524eb | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.48e-08 | 200 | 37 | 6 | a637281d91e95734ee4f8510b3780e0272b16fda | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.48e-08 | 200 | 37 | 6 | 6f7f015b5fa1f52374f2c7d9ba339012395eda5f | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_peribronchial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.48e-08 | 200 | 37 | 6 | efdf7066b7dd43e35dbc0d2719b75f250cf54af2 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.48e-08 | 200 | 37 | 6 | a2bb67a06757f19be3f56f8cb5bb7e2affa5f4ed | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.48e-08 | 200 | 37 | 6 | c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.48e-08 | 200 | 37 | 6 | 5a87bb8eb1c6bd2fbc357e1528e15ba1c0051438 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.48e-08 | 200 | 37 | 6 | 10f0c20ba7c71d9e2e177597f85b41cb40f0d878 | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Mac-Intermediate_macrophages|bone_marrow / Manually curated celltypes from each tissue | 2.71e-07 | 168 | 37 | 5 | 8ade4d098aeecda2d80c1cad1cebe9a063eae948 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.91e-07 | 181 | 37 | 5 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.02e-07 | 182 | 37 | 5 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.36e-07 | 185 | 37 | 5 | 87c416d14ca6255bee39b16e7571553e36ee3069 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.48e-07 | 186 | 37 | 5 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.60e-07 | 187 | 37 | 5 | 4e553721fa5598cb211f44e3226280b7e6885484 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.60e-07 | 187 | 37 | 5 | d36e7fc6125e7a4310499365022d38f34b757a73 | |
| ToppCell | facs-Trachea-nan-24m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.60e-07 | 187 | 37 | 5 | b930d5f7d410ac1f340babec5c937388f64cafc0 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.60e-07 | 187 | 37 | 5 | 827eae63fabf6892a82ce7779b5f395958d3d628 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 4.60e-07 | 187 | 37 | 5 | a96495803ba13fcfadd1d83b3cf5774f3fed0a20 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.72e-07 | 188 | 37 | 5 | 6c6486cae9a8f2f8200598cb4bfd3fd513eb28a3 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.85e-07 | 189 | 37 | 5 | 0a8b827bba1efd885ad6c06929251c741dc3a541 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.85e-07 | 189 | 37 | 5 | 56f43e00d81cf3cdf0c39f8d7120f5beab72e258 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.85e-07 | 189 | 37 | 5 | bc54ffd7bd1627a36747a80ce5139e4a69928400 | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 4.98e-07 | 190 | 37 | 5 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.98e-07 | 190 | 37 | 5 | bd0d68dc1b6f388190a6ba8a83b011619abe2bdd | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.98e-07 | 190 | 37 | 5 | f3ca94a31a35eed5fecf3c4b8c957e1bc4150158 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.98e-07 | 190 | 37 | 5 | e275de94468872e70cf305b3b450823d4c9c5e3f | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Mesenchymal-mesenchymal_stem_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.98e-07 | 190 | 37 | 5 | d13fd234caa3fc69d8a59bc0060cdacdf716ee55 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.98e-07 | 190 | 37 | 5 | ee2f4a55d2fd18b83e55399b5b5697a15a2d2e70 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.98e-07 | 190 | 37 | 5 | c2cd1eb674162ee40502c3380b7245c85079c7ce | |
| ToppCell | droplet-Mammary_Gland-nan-21m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.11e-07 | 191 | 37 | 5 | 8022059e434fd411dc539819f969bd4f94861281 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.11e-07 | 191 | 37 | 5 | 44a9a6768084dafc641ad455b65862bfd4cc0cb9 | |
| Computational | Neighborhood of CDH11 | 1.33e-07 | 25 | 21 | 4 | GNF2_CDH11 | |
| Computational | Adhesion molecules. | 6.22e-06 | 141 | 21 | 5 | MODULE_122 | |
| Computational | Neighborhood of PTX3 | 4.40e-05 | 36 | 21 | 3 | GNF2_PTX3 | |
| Computational | ECM and collagens. | 5.95e-05 | 225 | 21 | 5 | MODULE_47 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.19e-04 | 50 | 21 | 3 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_1 | |
| Computational | Ovary genes. | 5.92e-04 | 368 | 21 | 5 | MODULE_1 | |
| Computational | DRG (dorsal root ganglia) genes. | 7.18e-04 | 384 | 21 | 5 | MODULE_2 | |
| Drug | BM165 | 3.39e-12 | 11 | 36 | 5 | CID003352881 | |
| Drug | ALT-711 | 3.09e-08 | 21 | 36 | 4 | CID000216304 | |
| Drug | AC1L9INI | 3.48e-08 | 59 | 36 | 5 | CID000445839 | |
| Drug | Sikvav | 5.47e-08 | 24 | 36 | 4 | CID005487517 | |
| Drug | A0395 | 1.18e-07 | 75 | 36 | 5 | CID009906466 | |
| Drug | 2-[(1R,2R,3S,4R,5R,6S)-2-[(2R,5S)-3-[(3S,4S,5R,6S)-4,5-dihydroxy-3-(methylamino)-6-methylol-tetrahydropyran-2-yl]-4-formyl-4-hydroxy-5-methylol-tetrahydrofuran-2-yl]oxy-5-guanidino-3,4,6-trihydroxy-cyclohexyl]guanidine | 1.97e-07 | 83 | 36 | 5 | CID011968896 | |
| Drug | poly-N-acetyllactosamine | 2.64e-07 | 88 | 36 | 5 | CID000119547 | |
| Drug | Ikvav | 3.74e-07 | 38 | 36 | 4 | CID000131343 | |
| Drug | AC1L1G72 | 5.94e-07 | 11 | 36 | 3 | CID000003553 | |
| Drug | 2,4-diaminopyrimidine | 1.57e-06 | 54 | 36 | 4 | CID000067431 | |
| Drug | kalinin | 1.69e-06 | 55 | 36 | 4 | CID000032518 | |
| Drug | LG 5 | 2.41e-06 | 60 | 36 | 4 | CID011840957 | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 4.36e-06 | 155 | 36 | 5 | 6817_DN | |
| Drug | dysprosium | 5.60e-06 | 74 | 36 | 4 | CID000023912 | |
| Drug | 2-amino-5-methylpyridine | 6.56e-06 | 77 | 36 | 4 | CID000015348 | |
| Drug | YIGSR | 7.27e-06 | 79 | 36 | 4 | CID000123977 | |
| Drug | Grgds | 8.85e-06 | 83 | 36 | 4 | CID000123811 | |
| Drug | 5155877; Down 200; 10uM; MCF7; HT_HG-U133A | 1.27e-05 | 193 | 36 | 5 | 6574_DN | |
| Drug | AC1L1B58 | 1.29e-05 | 29 | 36 | 3 | CID000001288 | |
| Drug | Leucomisine [17946-87-1]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 1.30e-05 | 194 | 36 | 5 | 6767_DN | |
| Drug | Foliosidine [2520-38-9]; Down 200; 13uM; PC3; HT_HG-U133A | 1.40e-05 | 197 | 36 | 5 | 4295_DN | |
| Drug | Salsolinol hydrobromide [38221-21-5]; Up 200; 15.4uM; MCF7; HT_HG-U133A | 1.43e-05 | 198 | 36 | 5 | 2791_UP | |
| Drug | Ornidazole [16773-42-5]; Up 200; 18.2uM; HL60; HG-U133A | 1.47e-05 | 199 | 36 | 5 | 1425_UP | |
| Drug | Guanfacine hydrochloride [29110-48-3]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 1.50e-05 | 200 | 36 | 5 | 5621_UP | |
| Drug | Rgds Peptide | 2.33e-05 | 106 | 36 | 4 | CID000107775 | |
| Drug | 1-anilino-4-methyl-2-methylthio-4-phenylimidazolin-5-one | 2.39e-05 | 373 | 36 | 6 | ctd:C540355 | |
| Drug | Gdrgdsp | 2.60e-05 | 109 | 36 | 4 | CID000115346 | |
| Drug | Calcort | 2.95e-05 | 38 | 36 | 3 | CID000026709 | |
| Drug | B-Ms | 3.10e-05 | 114 | 36 | 4 | CID000445091 | |
| Drug | pyrachlostrobin | 3.12e-05 | 811 | 36 | 8 | ctd:C513428 | |
| Drug | Rgd Peptide | 3.53e-05 | 239 | 36 | 5 | CID000104802 | |
| Drug | quinaprilat | 4.29e-05 | 43 | 36 | 3 | CID000107994 | |
| Drug | FR 139317 | 5.08e-05 | 7 | 36 | 2 | ctd:C079574 | |
| Drug | hyaluronan | 5.57e-05 | 263 | 36 | 5 | CID000024759 | |
| Drug | funiferine N-oxide | 6.36e-05 | 49 | 36 | 3 | CID000191631 | |
| Drug | trypanothione disulfide | 6.92e-05 | 140 | 36 | 4 | CID000115098 | |
| Drug | dl-Lysine | 8.83e-05 | 290 | 36 | 5 | CID000000866 | |
| Drug | I-Q-S | 1.05e-04 | 156 | 36 | 4 | CID000003540 | |
| Drug | CC270 | 1.11e-04 | 59 | 36 | 3 | CID006918852 | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 1.19e-04 | 161 | 36 | 4 | 3556_DN | |
| Drug | 3',4'-dihydroxyflavone | 1.32e-04 | 11 | 36 | 2 | ctd:C028288 | |
| Drug | DB04780 | 1.47e-04 | 170 | 36 | 4 | CID005459389 | |
| Drug | Ribavirin [36791-04-5]; Up 200; 16.4uM; HL60; HT_HG-U133A | 1.91e-04 | 182 | 36 | 4 | 3142_UP | |
| Drug | colcemid; Up 200; 11.7uM; MCF7; HT_HG-U133A_EA | 2.25e-04 | 190 | 36 | 4 | 1103_UP | |
| Drug | Gramine [87-52-5]; Up 200; 23uM; MCF7; HT_HG-U133A | 2.34e-04 | 192 | 36 | 4 | 2799_UP | |
| Drug | Testosterone propionate [57-85-2]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 2.38e-04 | 193 | 36 | 4 | 5271_UP | |
| Drug | Metoclopramide monohydrochloride [7232-21-5]; Down 200; 11.8uM; PC3; HT_HG-U133A | 2.38e-04 | 193 | 36 | 4 | 4285_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A | 2.43e-04 | 194 | 36 | 4 | 2672_DN | |
| Drug | Dinoprost trometamol [38362-01-5]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 2.43e-04 | 194 | 36 | 4 | 3308_UP | |
| Drug | radicicol; Down 200; 0.1uM; MCF7; HG-U133A | 2.48e-04 | 195 | 36 | 4 | 489_DN | |
| Drug | Dihydroergocristine mesylate [24730-10-7]; Up 200; 5.6uM; MCF7; HT_HG-U133A | 2.48e-04 | 195 | 36 | 4 | 2895_UP | |
| Drug | trifluoperazine dihydrochloride; Up 200; 10uM; MCF7; HG-U133A | 2.48e-04 | 195 | 36 | 4 | 421_UP | |
| Drug | Clopamide [636-54-4]; Down 200; 11.6uM; HL60; HG-U133A | 2.48e-04 | 195 | 36 | 4 | 1605_DN | |
| Drug | Thalidomide [50-35-1]; Up 200; 15.4uM; MCF7; HT_HG-U133A | 2.48e-04 | 195 | 36 | 4 | 5990_UP | |
| Drug | Myosmine [532-12-7]; Up 200; 27.4uM; MCF7; HT_HG-U133A | 2.48e-04 | 195 | 36 | 4 | 3634_UP | |
| Drug | Betahistine mesylate [54856-23-4]; Up 200; 17.2uM; MCF7; HT_HG-U133A | 2.48e-04 | 195 | 36 | 4 | 2833_UP | |
| Drug | Piperacillin sodium salt [59703-84-3]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 2.53e-04 | 196 | 36 | 4 | 3420_UP | |
| Drug | Pargyline hydrochloride [306-07-0]; Up 200; 20.4uM; HL60; HG-U133A | 2.53e-04 | 196 | 36 | 4 | 1418_UP | |
| Drug | Clorsulon [60200-06-8]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 2.53e-04 | 196 | 36 | 4 | 2884_UP | |
| Drug | Molsidomine [25717-80-0]; Up 200; 16.6uM; MCF7; HT_HG-U133A | 2.53e-04 | 196 | 36 | 4 | 2862_UP | |
| Drug | THIP Hydrochloride; Up 200; 22.6uM; HL60; HT_HG-U133A | 2.53e-04 | 196 | 36 | 4 | 3132_UP | |
| Drug | Pivmecillinam hydrochloride [32887-03-9]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 2.53e-04 | 196 | 36 | 4 | 3535_UP | |
| Drug | Cefepime hydrochloride [123171-59-5]; Down 200; 7.4uM; MCF7; HT_HG-U133A | 2.58e-04 | 197 | 36 | 4 | 6237_DN | |
| Drug | Chlorhexidine [55-56-1]; Up 200; 8uM; MCF7; HT_HG-U133A | 2.58e-04 | 197 | 36 | 4 | 5403_UP | |
| Drug | Diflorasone Diacetate [33564-31-7]; Down 200; 8uM; MCF7; HT_HG-U133A | 2.58e-04 | 197 | 36 | 4 | 4158_DN | |
| Drug | 0179445-0000 [211246-22-9]; Up 200; 1uM; MCF7; HT_HG-U133A | 2.58e-04 | 197 | 36 | 4 | 4758_UP | |
| Drug | Pyrithyldione [77-04-3]; Up 200; 24uM; MCF7; HT_HG-U133A | 2.58e-04 | 197 | 36 | 4 | 6801_UP | |
| Drug | Mecamylamine hydrochloride [826-39-1]; Up 200; 19.6uM; MCF7; HT_HG-U133A | 2.58e-04 | 197 | 36 | 4 | 3525_UP | |
| Drug | Mexiletine hydrochloride [5370-01-4]; Down 200; 18.6uM; PC3; HT_HG-U133A | 2.58e-04 | 197 | 36 | 4 | 3781_DN | |
| Drug | Clozapine [5786-21-0]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 2.58e-04 | 197 | 36 | 4 | 5630_UP | |
| Drug | Piribedil hydrochloride [78213-63-5]; Up 200; 12uM; MCF7; HT_HG-U133A | 2.58e-04 | 197 | 36 | 4 | 3512_UP | |
| Drug | Spiramycin [8025-81-8]; Down 200; 4.8uM; HL60; HT_HG-U133A | 2.58e-04 | 197 | 36 | 4 | 2558_DN | |
| Drug | Ampyrone [83-07-8]; Down 200; 19.6uM; HL60; HG-U133A | 2.58e-04 | 197 | 36 | 4 | 1402_DN | |
| Drug | S(-)Eticlopride hydrochloride [97612-24-3]; Down 200; 10.6uM; HL60; HT_HG-U133A | 2.58e-04 | 197 | 36 | 4 | 3056_DN | |
| Drug | (R) -Naproxen sodium salt [26159-34-2]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 2.63e-04 | 198 | 36 | 4 | 6096_DN | |
| Drug | AG-013608 [351320-38-2]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.63e-04 | 198 | 36 | 4 | 5944_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 500uM; MCF7; HG-U133A | 2.63e-04 | 198 | 36 | 4 | 347_DN | |
| Drug | Trihexyphenidyl-D,L Hydrochloride [58947-95-8]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 2.63e-04 | 198 | 36 | 4 | 4133_DN | |
| Drug | Sulfachloropyridazine [80-32-0]; Down 200; 14uM; HL60; HT_HG-U133A | 2.63e-04 | 198 | 36 | 4 | 2191_DN | |
| Drug | Fenbufen [36330-85-5]; Up 200; 15.8uM; MCF7; HT_HG-U133A | 2.68e-04 | 199 | 36 | 4 | 3618_UP | |
| Drug | (R)-Propranolol hydrochloride [13071-11-9]; Up 200; 13.6uM; HL60; HT_HG-U133A | 2.68e-04 | 199 | 36 | 4 | 6130_UP | |
| Drug | PHA-00851261E [724719-49-7]; Up 200; 1uM; MCF7; HT_HG-U133A | 2.73e-04 | 200 | 36 | 4 | 3968_UP | |
| Drug | Khellin [82-02-0]; Up 200; 15.4uM; MCF7; HT_HG-U133A | 2.73e-04 | 200 | 36 | 4 | 1504_UP | |
| Drug | Alprenolol hydrochloride [13707-88-5]; Down 200; 14uM; MCF7; HT_HG-U133A | 2.73e-04 | 200 | 36 | 4 | 6789_DN | |
| Drug | Sas 1 | 2.88e-04 | 16 | 36 | 2 | CID006328170 | |
| Drug | NSC 714187 | 3.28e-04 | 85 | 36 | 3 | CID005288693 | |
| Drug | 1,2-dimethylhydrazine | 3.39e-04 | 86 | 36 | 3 | CID000001322 | |
| Drug | cobalt-60 | 3.50e-04 | 390 | 36 | 5 | CID000061492 | |
| Drug | pifarnine | 3.66e-04 | 18 | 36 | 2 | CID006436032 | |
| Drug | H-9 dihydrochloride | 3.88e-04 | 90 | 36 | 3 | CID000003544 | |
| Drug | dermatan sulfate | 3.92e-04 | 220 | 36 | 4 | CID000032756 | |
| Drug | chondroitin sulfate | 4.55e-04 | 413 | 36 | 5 | CID000024766 | |
| Drug | LMWH | 5.51e-04 | 663 | 36 | 6 | CID000000772 | |
| Disease | autosomal recessive nonsyndromic deafness 16 (implicated_via_orthology) | 1.37e-06 | 2 | 35 | 2 | DOID:0110471 (implicated_via_orthology) | |
| Disease | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy | 1.37e-06 | 2 | 35 | 2 | cv:C0751587 | |
| Disease | CADASIL Syndrome | 1.37e-06 | 2 | 35 | 2 | C0751587 | |
| Disease | CADASILM | 1.37e-06 | 2 | 35 | 2 | C1449626 | |
| Disease | Marfan Syndrome, Type I | 4.89e-05 | 9 | 35 | 2 | C4721845 | |
| Disease | Marfan Syndrome | 7.47e-05 | 11 | 35 | 2 | C0024796 | |
| Disease | Glioblastoma | 1.14e-04 | 79 | 35 | 3 | C0017636 | |
| Disease | Impaired cognition | 1.23e-04 | 14 | 35 | 2 | C0338656 | |
| Disease | Giant Cell Glioblastoma | 1.36e-04 | 84 | 35 | 3 | C0334588 | |
| Disease | caffeine measurement | 1.42e-04 | 15 | 35 | 2 | EFO_0021177 | |
| Disease | Dementia | 1.84e-04 | 17 | 35 | 2 | C0497327 | |
| Disease | Glioblastoma Multiforme | 3.11e-04 | 111 | 35 | 3 | C1621958 | |
| Disease | Myasthenic Syndromes, Congenital | 3.71e-04 | 24 | 35 | 2 | C0751882 | |
| Disease | intestinal permeability measurement | 4.36e-04 | 26 | 35 | 2 | EFO_0011031 | |
| Disease | Hyalinosis, Segmental Glomerular | 5.07e-04 | 28 | 35 | 2 | C0086432 | |
| Disease | spontaneous coronary artery dissection | 6.22e-04 | 31 | 35 | 2 | EFO_0010820 | |
| Disease | myocardial infarction | 7.62e-04 | 350 | 35 | 4 | EFO_0000612 | |
| Disease | Focal glomerulosclerosis | 8.40e-04 | 36 | 35 | 2 | C0017668 | |
| Disease | diabetes mellitus (is_marker_for) | 1.09e-03 | 41 | 35 | 2 | DOID:9351 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HCREGGPAPRGACEG | 261 | Q9P281 | |
| RGSGVGECGDHPCLP | 1541 | O00468 | |
| GECGDHPCLPNPCHG | 1546 | O00468 | |
| PCHGAAPCRVLPEGG | 1596 | O00468 | |
| PGNARCADCGAPDPD | 16 | O75689 | |
| EGGHGCPDAPACGPV | 256 | Q7Z5Q5 | |
| DGTDEEDCPGCPPGH | 346 | Q7Z4F1 | |
| EDCPGCPPGHFPCGA | 351 | Q7Z4F1 | |
| FCRNPDGDPGGPWCH | 126 | Q2TV78 | |
| HPDGRFECRCPPGFG | 1111 | Q5IJ48 | |
| HPECGDKGCDGPNAD | 696 | P29122 | |
| VDECAGPAPCGPHGI | 811 | Q9UM47 | |
| GDHCRPCPCPDGPDS | 911 | P07942 | |
| EACAPGHFGDPSRPG | 966 | P55268 | |
| GREGPAGACEPCGPR | 381 | Q5JZY3 | |
| PADPCHDEGGAPRGC | 26 | O00634 | |
| CPPQPEHCEGGRARD | 46 | Q92743 | |
| CDNCRRPGGEPSPEG | 2421 | P02751 | |
| DGGRGWGPHCEICPF | 2366 | P35555 | |
| GECCQRPGPDLHPCG | 281 | Q99871 | |
| SFECICPPGHRAGPD | 941 | Q8N2S1 | |
| EEPPRCAGPGAHAGL | 446 | P40197 | |
| PPWHCGDRGDCGDRG | 366 | O15037 | |
| GPEGCKPCDCHPEGS | 976 | P11047 | |
| GGVCCFEHLPGGDPD | 36 | Q8NEL9 | |
| CRAPGQPPGAALCHG | 51 | O95965 | |
| AARRPCGCPLGGEDP | 171 | Q5VY09 | |
| PEGCPCGLPHGESAL | 66 | Q8N2A8 | |
| WDCPDGADEGPGHCP | 1516 | A2VEC9 | |
| DERGCGGPCAPHHAP | 1596 | A2VEC9 | |
| EAAPAAGHDPDCAGC | 536 | Q6ZMQ8 | |
| AGHDPDCAGCAPSPP | 541 | Q6ZMQ8 | |
| EECPLGWHGPGCQRP | 391 | Q9UK23 | |
| GDGAGDCAHPDPRAP | 11 | Q8TCU6 | |
| CAACGGAHEGPALEP | 36 | Q9Y2L1 | |
| PPCHIGPCGERCPDG | 516 | Q7RTU9 | |
| DCRDPARGTAPGCPG | 116 | Q8TCV5 | |
| GGCRDGHCSPPAAGD | 691 | A7XYQ1 | |
| GRDCQACPGGPDAPC | 1956 | Q8WWQ8 | |
| PPCHIGPCGERCPDG | 516 | A6NGW2 | |
| DGDAGQPPLHCPFCD | 1416 | P52746 | |
| GERPYTCPEPHCGRG | 281 | P36508 |